Arrowhead Pharmaceuticals, Inc. (ARWR)

Nasdaq · Healthcare · Biotechnology
$47.65-3.46%As of 2026-11-12 · USD
Day low $46.98Day high $48.99
52-week low $37.0652-week high $95.49
Market cap
$6.64B
Sector
Healthcare
P/E (TTM)
45.4x
Next earnings
2026-11-12

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-12 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)24.2In the oversold range (below 30)
MACD (12, 26, 9)-3.78Below its signal line (-2.98); histogram -0.80
Bollinger %B (20, 2)-5%Below the lower band (48.42 to 65.33)
SMA 2056.87Price is 16.2% below
SMA 5064.11Price is 25.7% below
SMA 20071.19Price is 33.1% below
ATR (20)6.32% of priceAverage true range per day
52-week position18%In the lower part of the 37.06 to 95.49 range

About Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States.

Insider filings, 90 daysNo purchases and 2 sales (about $1.2M).
Latest fiscal yearEnded 2025-09-30: revenue of $829.45M and an operating margin of 11.9%.
Next earnings reportExpected on 2026-11-12.

More in Biotechnology